Aegirbio Ab (Publ)

Aegirbio, envision a future where nearly everyone could easily and continuously monitor health issues by promoting the development of novel diagnostics. Aegirbio aims to increase the supply and sophistication of diagnostic technologies, including the ability to differentiate between diseases that present with similar symptoms, identify the presence of latent infectious agents, and provide practical low-cost monitoring for treatment efficacy and disease recurrence. Aegirbio’s ambition is, in addition to bringing to market innovative diagnostic technologies, to make diagnostics: more accessible, easier to use, give accurate and easy transferable results.